Valuation: Adimmune Corporation

Market Cap 724.99Cr 23Cr 20Cr 19Cr 17Cr 32Cr 2.19TCr 32Cr 222.66Cr 86Cr 1.11TCr 86Cr 84Cr 3.52TCr P/E 2024
-34.7x
P/E 2025 -33.2x
Enterprise Value 786.22Cr 25Cr 21Cr 20Cr 18Cr 34Cr 2.37TCr 35Cr 241.46Cr 93Cr 1.2TCr 93Cr 91Cr 3.82TCr EV / Sales 2024
5.53x
EV / Sales 2025 6.14x
Free-Float
70.19%
Yield 2024 *
-
Yield 2025 -
1 week-1.99%
Current month-3.10%
1 month-0.58%
3 months-2.55%
6 months-1.71%
Current year-9.23%
1 week 17.05
Extreme 17.05
17.85
1 month 17.05
Extreme 17.05
18.55
Current year 16.4
Extreme 16.4
21.5
1 year 16.4
Extreme 16.4
22.5
3 years 15.9
Extreme 15.9
36.6
5 years 15.9
Extreme 15.9
54.2
10 years 15.9
Extreme 15.9
79.8
Manager TitleAgeSince
Chief Executive Officer - 20/06/2019
Director of Finance/CFO - 01/01/2021
Chief Tech/Sci/R&D Officer - 26/01/2022
Director TitleAgeSince
Director/Board Member - 20/06/2019
Director/Board Member - 15/08/2011
Director/Board Member - 29/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.99%-6.52%-48.73% 23Cr
+1.63%-1.92%+38.80%-4.52% 7.8TCr
+1.45%+3.76%+509.72%+29.07% 5.75TCr
+2.68%-1.68%-17.44%-36.27% 5.74TCr
+0.35%-1.87%-11.03%+27.74% 4.88TCr
+2.38%+0.10%+2.43%+155.34% 4.55TCr
+0.29%+2.48%+51.95%-15.04% 3.21TCr
+0.88%-1.54%+47.32%+92.94% 2.46TCr
+3.53%-5.42%-1.02%+170.53% 2.08TCr
+2.24%-0.40%+64.18%+100.09% 1.57TCr
Average +1.54%-3.48%+67.84%+47.12% 3.81TCr
Weighted average by Cap. +1.65%-3.44%+91.20%+38.27%

Financials

2024 2025
Net sales 155.7Cr 4.9Cr 4.24Cr 4Cr 3.63Cr 6.81Cr 469.29Cr 6.86Cr 48Cr 18Cr 238.07Cr 18Cr 18Cr 756.87Cr 140.15Cr 4.41Cr 3.82Cr 3.6Cr 3.27Cr 6.13Cr 422.43Cr 6.18Cr 43Cr 17Cr 214.3Cr 17Cr 16Cr 681.29Cr
Net income -24Cr -76.34L -66.15L -62.42L -56.63L -1.06Cr -73Cr -1.07Cr -7.46Cr -2.87Cr -37Cr -2.87Cr -2.8Cr -118Cr -24Cr -75.44L -65.37L -61.69L -55.96L -1.05Cr -72Cr -1.06Cr -7.37Cr -2.84Cr -37Cr -2.83Cr -2.77Cr -116.61Cr
Net Debt 14Cr 43.89L 38.03L 35.89L 32.56L 61.07L 42Cr 61.52L 4.29Cr 1.65Cr 21Cr 1.65Cr 1.61Cr 68Cr 61Cr 1.93Cr 1.67Cr 1.57Cr 1.43Cr 2.68Cr 184.55Cr 2.7Cr 19Cr 7.25Cr 94Cr 7.23Cr 7.07Cr 297.64Cr
Logo Adimmune Corporation
Adimmune Corp is a Taiwan-based company mainly engaged in the research, development, processing, manufacturing, and sales of serums, vaccines, diagnostic reagents, biological agents, bacterial cultures, and raw materials. The Company's main products are influenza vaccines and non-influenza vaccines. Tetanus vaccines are used to prevent tetanus. Influenza vaccines are used to prevent seasonal influenza viruses. Tuberculin skin tests are used to determine whether a patient is infected with Mycobacterium tuberculosis. The Company primarily sells its products domestically and internationally.
Employees
564
Date Price Change Volume
14/26/14 NT$17.20 0.00% 4,98,268
11/26/11 NT$17.20 -1.71% 7,77,192
10/26/10 NT$17.50 -1.41% 4,96,151
09/26/09 NT$17.75 +1.14% 4,41,243
08/26/08 NT$17.55 -0.85% 6,53,045
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4142 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!